Losartan News and Research

RSS
Losartan is a drug used to treat high blood pressure. Losartan blocks the action of chemicals that make blood vessels constrict (get narrower). It is a type of angiotensin II receptor antagonist. Also called Cozaar and losartan potassium.
Teva third quarter net sales increase 20% to $4.3 billion

Teva third quarter net sales increase 20% to $4.3 billion

Merck reports $342 million net income for 2010 third quarter

Merck reports $342 million net income for 2010 third quarter

Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs

Mylan granted FDA approvals for generic Hyzaar and Cozaar ANDAs

ANDA approved for Losartan Potassium Tablets USP, Losartan Potassium and Hydrochlorothiazide Tablets

ANDA approved for Losartan Potassium Tablets USP, Losartan Potassium and Hydrochlorothiazide Tablets

Benicar better than Cozaar in reducing blood pressure: Study

Benicar better than Cozaar in reducing blood pressure: Study

Tracking heart rate can provide important marker of health issues: Research

Tracking heart rate can provide important marker of health issues: Research

Merck reports strong bottom-line performance in second quarter

Merck reports strong bottom-line performance in second quarter

Teva second-quarter net sales increase 12% to $3.8 billion

Teva second-quarter net sales increase 12% to $3.8 billion

Proteinuria screening identifies risk for kidney disease progression

Proteinuria screening identifies risk for kidney disease progression

ARBs may be linked with increased risk of developing cancer: US scientists

ARBs may be linked with increased risk of developing cancer: US scientists

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries

Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Merck announces global sales of $27.4 billion for full-year 2009

Merck announces global sales of $27.4 billion for full-year 2009

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings announces completion of clinical trials for Candesartan

Study: Larger dose of ARBs is more effective in heart failure patients

Study: Larger dose of ARBs is more effective in heart failure patients

Merck's sales increases by 2% in third quarter 2009

Merck's sales increases by 2% in third quarter 2009

Findings may yield new treatments for COPD

Findings may yield new treatments for COPD